March 1, 2018 / 8:04 AM / 2 years ago

BRIEF-Natco Pharma Files ANDA to U.S. FDA For Sofosbuvir Tablets

March 1 (Reuters) - Natco Pharma Ltd:

* SAYS FILED AN ABBREVIATED NEW DRUG APPLICATION FOR SOFOSBUVIR TABLETS, 400MG, WITH U.S.‍​ FDA

* SAYS DRUG IS USED FOR TREATMENT OF CHRONIC HEPATITIS C INFECTION Source text: bit.ly/2F5vduT Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below